HR
Harrow Health, Inc. 11.875% Senior Notes due 2027
HROWM · NASDAQ
$26.03 -0.08% (-$0.02)
Valuation
-
N/A P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
-
N/A Asset turnover N/A
ROA N/A
ROIC N/A
Debt
-
N/A Net debt/EBITDA N/A
Int. coverage N/A
Debt/Equity N/A
Stability
0 /100
Unstable Beta 0.14x
EPS volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HROWM
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Mark L. Baum
Employees
217
Headquarters
Nashville